Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Orphan drugs

Ocugen
Products and Services

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate

February 25, 2021February 25, 2021 - by MyChesCo

MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …

Read More

Food and Drug Administration
Health / Medical / National

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

November 25, 2020November 24, 2020 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate …

Read More
VA Recruiting Volunteers for COVID-19 Clinical Trials
Infectious Diseases / National / Research

VA Recruiting Volunteers for COVID-19 Clinical Trials

November 17, 2020November 17, 2020 - by MyChesCo

WASHINGTON, D.C. — As part of the U.S. Department of Veterans Affairs (VA) fight against the COVID-19 pandemic, the department announced its nationwide effort to recruit volunteers for COVID-19 clinical …

Read More

Zynerba Pharmaceuticals
Business / Research

Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome

September 19, 2020September 18, 2020 - by MyChesCo

DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) announced that the U.S. Food and Drug Administration has granted orphan drug designation for cannabidiol (CBD) for use in treating 22q11.2 deletion …

Read More
Ocugen
Products and Services

Ocugen Granted FDA Orphan Drug Designation for OCU400 (AAV-hNR2E3) Gene Therapy

July 28, 2020July 28, 2020 - by MyChesCo

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced the U.S. Food and Drug Administration (FDA) …

Read More

U.S. Food and Drug Administration (FDA)
Government / National / Research

FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

July 27, 2020July 25, 2020 - by MyChesCo

The U.S. Food and Drug Administration recently approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded …

Read More

Most Read

  • Mother of Three Sentenced to 14 Years for Traveling to Pennsylvania to Have Sex with Teenager
  • Two Suspects Wanted in Alleged Theft at PacSun
  • The Definitive Ranking of Best Cheesesteaks in Chester County
  • Lancaster County Youth Pastor Charged with Child Pornography
  • February 25 COVID-19 Update: 87,264 Vaccinations to Date in Chester County
  • Police Asking for Help Identifying Walmart Theft Suspects

Subscribe for Updates

Chester County Events

  • Beer and Bonsai at Victory Taprooms Parkesburg
    • 03/04/2021
      Parkesburg
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/06/2021
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/07/2021
  • Real World Self Defense and Law
    • 03/07/2021
      Elverson
  • Coatesville Country Club
    • 03/07/2021
      Coatesville
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate
  • Chester County Pharmacy Agrees to Resolve Civil Allegations of Improper Dispensing of Controlled Substances
  • 20 Immaculata University Nursing Students Receive “Nurses for Tomorrow” Scholarships
  • Weekday Lane Closure to Take Effect Next Week on Route 401, Conestoga Road
Copyright © 2021 MyChesCo.